Cutting Edge: Predetermined Avidity of Human CD8 T Cells Expanded on Calibrated MHC/Anti-CD28-Coated Microspheres 1
暂无分享,去创建一个
Hans-Georg Rammensee | Gundram Jung | Steffen Walter | Dorothee Wernet | H. Rammensee | S. Stevanović | O. Schoor | L. Herrgen | S. Walter | D. Wernet | H. Bühring | G. Jung | Leah Herrgen | Stefan Stevanović | Oliver Schoor | Hans-Jörg Bühring
[1] H. Rammensee,et al. Human platelets express heat shock protein receptors and regulate dendritic cell maturation. , 2002, Blood.
[2] Philip J. R. Goulder,et al. Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.
[3] V. Cerundolo,et al. Mature Dendritic Cells Prime Functionally Superior Melan-A-Specific CD8+ Lymphocytes as Compared with Nonprofessional APC1 , 2001, The Journal of Immunology.
[4] H. Müller-Eberhard,et al. Induction of cytotoxicity in resting human T lymphocytes bound to tumor cells by antibody heteroconjugates. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[5] D. Speiser,et al. High Frequencies of Naive Melan-a/Mart-1–Specific Cd8+ T Cells in a Large Proportion of Human Histocompatibility Leukocyte Antigen (Hla)-A2 Individuals , 1999, The Journal of experimental medicine.
[6] C. Wilson,et al. HIV-1-specific CTL responses primed in vitro by blood-derived dendritic cells and Th1-biasing cytokines. , 1999, Journal of immunology.
[7] Michel Sadelain,et al. Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells , 2000, Nature Biotechnology.
[8] M. Mescher,et al. Cell-sized, supported artificial membranes (pseudocytes): response of precursor cytotoxic T lymphocytes to class I MHC proteins. , 1986, Journal of immunology.
[9] J. Berzofsky,et al. Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[10] D. Speiser,et al. Functional Avidity of Tumor Antigen-Specific CTL Recognition Directly Correlates with the Stability of MHC/Peptide Multimer Binding to TCR1 , 2002, The Journal of Immunology.
[11] H. Grey,et al. Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[12] P. Kourilsky,et al. In vitro induction of naive cytotoxic T lymphocytes with complexes of peptide and recombinant MHC class I molecules coated onto beads: role of TCR/ligand density , 1998, European journal of immunology.
[13] M R Jackson,et al. Requirements for stimulating naive CD8+ T cells via signal 1 alone. , 1998, Journal of immunology.
[14] M. Davis,et al. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers. , 1999, Journal of immunology.
[15] A. Mackensen,et al. Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig–coated artificial antigen-presenting cells , 2003, Nature Medicine.
[16] M. Jenkins,et al. Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells. , 1999, Journal of immunology.
[17] H. Rammensee,et al. SYFPEITHI: database for MHC ligands and peptide motifs , 1999, Immunogenetics.
[18] M. Raffeld,et al. Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes , 2002, Science.